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Objective: Endoleaks and endotension are critically important complications of some endovascular aortic aneurysm repairs
(EVARs). For the resolution of controversial issues and the determination of areas of uncertainty relating to these
complications, a conference of 27 interested leaders was held on November 20, 2000.
Methods: These 27 participants (21 vascular surgeons, five interventional radiologists, one cardiologist) had previously
answered 40 key questions on endoleaks and endotension. At the conference, these 40 questions and participant answers
were discussed and in some cases modified to determine points of agreement (consensus), near consensus (prevailing
opinion), or disagreement.
Results: Conference discussion added two modified questions for a total of 42 key questions for the participants.
Interestingly, consensus was reached on the answers to 24 of 42 or 57% of the questions, and near consensus was reached
on 14 of 42 or 33% of the questions. Only with the answers to four of 42 or 10% of the questions was there persistent
controversy or disagreement.
Conclusion: The current endoleak classification system with some important modifications is adequate. Types I and II
endoleak occur after 0 to 10% and 10% to 25% of EVARs, respectively. Many (30% to 100%) type II endoleaks will seal
and have no detrimental effect, which never or rarely occurs with type I endoleaks. Not all endoleaks can be visualized
with any technique, and increased pressure (endotension) can be transmitted through clot. Aneurysm pulsatility after
EVAR correlates poorly with endoleaks and endotension. An enlarging aneurysm after EVAR mandates surgical or
interventional treatment. These and other conclusions will help to resolve controversy and aid in the management of these
vexing complications and should also point the way to future research in this field. (J Vasc Surg 2002;35:1029-35.)
Endovascular abdominal aortic aneurysm repair
(EVAR) has been performed since 1990.1 A variety of
endograft devices have been used at centers around the
world.2-6 Although many dramatically successful early re-
sults have been achieved and many advantages are claimed,
the mid-term and long-term durability of these grafts and
their effectiveness in prevention of rupture remain ques-
tionable.7-10 One of the principal reasons for failure after
the 1st year is the occurrence of endoleaks, defined as
persistent blood flow outside the graft and within the
aneurysm sac.11 Another reason is the presence of endoten-
sion, defined as a state of elevated pressure within the
aneurysm sac.12
That endoleaks and endotension are critically impor-
tant complications of many EVARs is widely but not uni-
versally agreed. However, many aspects of the nature,
incidence, and significance of these problems are highly
controversial. Some investigators believe that most en-
doleaks do not influence the outcome of EVARs,13 whereas
others consider most to be serious and the Achilles’ heel of
the procedure.10,11 In addition, wide differences of opinion
exist regarding the best treatment for endoleaks and endo-
tension. Even the classification systems for these problems
and the relationship between them remain subjects of con-
troversy.14,15
To resolve some of these controversies and the conflict-
ing recommendations for management related to en-
doleaks and endotension, a conference was held and in-
cluded experts from several disciplines interested in EVAR
in an attempt to reach agreement on as many key issues
related to endoleaks and endotension as possible. Another
purpose was to define areas of uncertainty or unanswered
questions regarding these two entities. This article summa-
From the Montefiore Medical Center/Albert Einstein College of Medicine;
and the Hospital of the University of Pennsylvania.
Supported in part by grants from the William J. von Liebig Foundation, the
Guidant Corporation, Medtronic Inc, the James Hilton Manning and
Emma Austin Manning Foundation, and the Anna S. Brown Trust.
Competition of interest: nil.
Reprint requests: Frank J. Veith, MD, Montefiore Medical Center, 111 E
210th St, New York, NY 10467.
Copyright © 2002 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2002/$35.00  0 24/1/123095
doi:10.1067/mva.2002.123095
1029
rizes the results of this consensus-seeking process and pro-
vides an overview of the current state of knowledge con-
cerning endoleaks and endotension. This information
should be helpful in guiding patient management decisions
and may also prove useful in evaluating the overall effec-
tiveness of EVAR and in guiding future investigations
relating to these two important complications.
METHODS
To provide the most informed yet balanced overview of
the endoleak/endotension field, the conference organizers
(F.J.V., R.A.B.) selected as participants physicians who,
irrespective of the specialty they represented, had the widest
experience and greatest interest in endoleaks and endoten-
sion and who had studied these processes and published
most extensively on them. Twenty-seven participants were
chosen from three different specialties (Vascular Surgery,
Interventional Radiology, and Interventional Cardiology)
and nine different countries (United States, United King-
dom, France, Germany, Denmark, Sweden, Australia, Ar-
gentina, and the Netherlands). As shown in Table I, 20 of
these participants were vascular surgeons, four were inter-
ventional radiologists, one was an expert in vascular imag-
ing techniques, and one was an interventional cardiologist.
All of the participants had extensive experience with EVAR
or evaluation of patients for EVAR before or after the
procedure. All had lectured and written widely about the
diagnoses or management of endoleaks and endotension.
All 27 of the selected participants agreed to take part in the
process and its subsequent documentation.
Before the oral conference. All participants were sent
a questionnaire requesting their responses to 40 key ques-
tions relating to endoleaks and endotension. These ques-
tions related to the timing, incidence, and nature of en-
doleaks and endotension, how they should be classified,
how they should be diagnosed and managed, and how they
are related to each other and to the outcomes of EVAR.
These questions were designed to evaluate current points of
agreement or disagreement about various critical issues
regarding these complications. The answers to these ques-
tions plus discussion at the oral session served as the basis
for the written documentation of the process. The ques-
tionnaire had room for comments in addition to the
“agree,” “disagree,” or “uncertain” answers or percentage
answers that were possible for most of the questions.
Oral consensus conference. The conference was held
in New York City on November 20, 2000. A summary and
analysis of the participant answers to each of the 40 original
questions was presented. Discussion of each question and
its answers followed. Two questions were modified slightly
to permit answers to which most participants could agree.
In other instances, participant answers were changed as the
question was clarified with the discussion. After free discus-
sion of each question and issue, a summary statement was
made regarding each.
Written documentation. This article summarizes the
participant answers to the most important and controversial
questions posed and will also provide a prevailing opinion
overview summarizing current thinking regarding en-
doleaks and endotension. It will highlight areas of uncer-
tainty and directions for future investigation. In addition, a
book will be published representing the results of the
conference process in greater detail, with articles from most
participants (Marcel Dekker, unpublished data).
Definitions. Answers to all 42 questions were ana-
lyzed and interpreted according to the following defini-
tions. If 18 or more of the 26 responding participants
agreed on a response to a question, that answer was con-
sidered to represent consensus or general agreement. If 14 to
17 of the 26 respondents agreed, that response was consid-
ered to represent near consensus or prevailing opinion. If less
than 14 of the 26 participants agreed on a response to a
question, that response was considered an area of divided
opinion, disagreement, or uncertainty.
RESULTS
Overall results
Of the 40 questions originally posed to the conference
participants, consensus or agreement with regard to the
answer was attained on 22, and near consensus or prevailing
opinion on an additional 14. The answers to the four
remaining original questions reflected divided opinion or
wide ranges of opinion, on the basis of conflicting views,
uncertainty, or actual disagreement. In addition, at the oral
conference, two derivative or altered questions were posed.
With these modified questions, the answers were converted
from prevailing opinion to consensus. Thus, consensus was
reached on 24 of 42 or 57% of the answers to key questions
posed, and near consensus was reached on 14 of 42 or 33%
of the answers. Only with the answers to four of the 42 or
10% of the questions was there a wide range of divergent
opinions.
The important areas of agreement included the follow-
ing questions and answers.
Table I. Consensus participants
Vascular surgeons
Interventional
radiologists
Interventional
cardiologist
Veith Meier Baum Amor
Adisehsiah Malina Ivancev
Blankensteijn Makaroun Katzen
Buth Ohki Richter
Chuter Parodi Rubin*
Fairman Stelter
Gilling-Smith White, G.
Harris White, R.
Hodgson Wisselink
Hopkinson Zarins
Lawrence-Brown
*Expert in vascular imaging.
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Agreement Relating to Nature or Behavior of
Endoleaks and Endotension
If a type I or type III endoleak is detected and then
sealed (cannot be visualized on computerized tomo-
graphic scans), it will have no bad consequence? Of the
26 respondents, 20 disagreed, although one respondent
stated that it could happen and another indicated that it
could if abdominal aortic aneurysm (AAA) shrinkage oc-
curred. Thus, consensus was reached that type I and type
III endoleaks will have serious consequences, even if sealing
appears to have occurred. The implication is that pressure
can be transmitted through clot.
If a type II endoleak is detected and then sealed
(cannot be visualized on computed tomographic scans),
it will usually have no bad consequences? Twenty-one
of the 26 respondents agreed with some qualifications. One
commented “unless the AAA enlarges.” Thus, consensus
was reached that sealed type II endoleaks are usually be-
nign. This question without the word “usually” elicited
agreement by only 17 participants, indicating that not all
type II endoleaks are benign.
Agreement Relating to Incidence of Endoleaks and
Endotension
What is the total percentage of type I endoleaks at
your institution (after 24 hours)? The answers ranged
from 0 to 30%, with a mean of 7.5%. Twenty of the 26
responses (consensus) ranged from 0 to 10%. One com-
ment indicated that the incidence rate was dependent on
patient selection.
What is the total percentage of type II endoleaks at
your institution (after 24 hours)? The answers ranged
from 5% to 40%, with a mean of 17%. Eighteen of the 26
responses (consensus) ranged from 10% to 25%.
What percentage of type II endoleaks seal and have
no detrimental effect? The answers ranged from 13% to
100%, with a mean of 53%. Eighteen of the 26 responses
(consensus) ranged from 30% to 90%. One comment indi-
cated that most type II endoleaks that seal are those de-
tected at the original procedure. Thus, again consensus was
reached that most but not all type II endoleaks will seal and
behave benignly.
What percentage of patients in your institution will
have delayed endoleaks develop within 3 years of endo-
vascular abdominal aortic aneurysm repair? Answers
ranged from 0 to 30%, with a mean of 10%. Eighteen of the
26 responses (consensus) ranged from 4% to 30%. Al-
though two respondents answered 0%, another respondent
commented that a delayed endoleak indicated a “missed”
endoleak or device failure. However, the consensus was
that delayed endoleaks do occur.
Agreement Relating to Diagnosis of Endoleaks and
Endotension
Contrast computed tomographic scans with de-
layed images are the best method to detect endoleaks?
Twenty of the 26 respondents agreed. Thus, consensus was
reached that computed tomographic (CT) scans are cur-
rently the best method for detecting endoleaks, although
comments were made that this method is not sensitive
enough and that angiography determines the etiology
more specifically.
Endoleaks can always be detected with appropri-
ately delayed computed tomographic scans? Twenty-
two of the 26 respondents disagreed. Thus, consensus was
reached that some endoleaks could not be detected with
even optimal CT scanning.
Simple diameter measurements are an adequate
method to follow abdominal aortic aneurysm size and
to document enlargement? Eighteen of the 26 respond-
ents agreed. Thus, consensus was reached that simple di-
ameter measurements could document AAA enlargement.
However, comments were made that careful comparative
measurements must be made and that focal enlargement
could be missed.
Duplex scans are the best method to detect en-
doleaks? Eighteen of the 26 respondents disagreed. Con-
sensus was, therefore, reached that duplex ultrasonogra-
phy, although useful, was not the best method for
detection of endoleaks. A comment was made that it was
not accurate in detection of type II endoleaks.
Enlargement of an abdominal aortic aneurysm by
more than 0.5 cm is indicative of endotension or an
endoleak? With some qualifications, 19 of the 26 respond-
ents agreed (consensus). Three believed an 8-mm increase
is required because of measurement difficulties, and one
was more comfortable with volume measurement changes.
Agreement Relating to Prevention and Treatment of
Endoleaks and Endotension
Patent lumbar and inferior mesenteric branches
should be treated in some way before endovascular
abdominal aortic aneurysm repair? Twenty-three re-
spondents disagreed. Thus, consensus was reached that
such pretreatment should not be performed.
Patent hypogastric branches that can reflux into
common iliac aneurysms giving rise to endoleaks
should be treated in some way before endovascular
abdominal aortic aneurysm repair? Nineteen of the 26
respondents agreed. Thus, consensus was reached on this
issue, although five disagreed and two were uncertain.
Coils placed within the area of contrast visualiza-
tion within an excluded abdominal aortic aneurysm sac
after endovascular abdominal aortic aneurysm repair
will result in thrombosis of any endoleak and elimina-
tion of endotension? Twenty-one of the respondents dis-
agreed. Thus, consensus was reached that such sac coiling
would be ineffective in treatment of particularly a type I or
type III leak. Even if clot were induced, pressure would be
transmitted to the sac wall. A possible exception was
thought by some to be a type II leak in which thrombosis of
a long branch might lead to decreased sac pressure.
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An enlarging abdominal aortic aneurysm after en-
dovascular abdominal aortic aneurysm repair without
evidence of an endoleak should usually be repaired
surgically or with a new endograft? Twenty of 26 re-
spondents agreed. Thus, consensus was reached on the
requirement for aggressive treatment in this circumstance.
Two participants commented with the reservation that the
AAA must be threateningly large and the patient suitably fit
to withstand the procedure.
If a type II endoleak is to be repaired, what is your
primary method of choice to do so? Twenty-two of the
26 respondents indicated that transarterial coil emboliza-
tion was their preferred method via the hypogastric or
superior mesenteric arteries. Several commented that it was
essential to get as close to the AAA sac as possible. Several
also commented that this method may be ineffective. Two
respondents commented that laparoscopic branch clipping
was their primary option, although it was the opinion of
others that translumbar approaches will gain increasing
recognition and use.16
Agreement Relating to Abdominal Aortic Aneurysm
Pulsatility and Endoleaks and Endotension
If an abdominal aortic aneurysm is nonpulsatile on
physical examination after endovascular abdominal
aortic aneurysm repair, it indicates there is no endoleak
or endotension? Eighteen of the 26 participants dis-
agreed. Thus, consensus was reached that decreased AAA
pulsatility on physical examination was not a good method
for assuring freedom from an endoleak or endotension.
One comment indicated that type II endoleaks rarely cause
AAA pulsatility.
Prevailing opinion was reached on answers to the
following questions.
Classification of Endoleaks and Endotension and
Relationship Between the Two
The current endoleak classification system (types I
to IV) is adequate? Seventeen of the 26 respondents
answered that it is, although with some qualifications.
Thus, the prevailing opinion was that, with some modifica-
tions, the current classification system for endoleaks and
endotension is adequate. The modified classification system
is detailed in Table II. Additional classifiers or descriptors
are included in the footnote to Table II.
Finally, endoleaks and endotension may be associated
with AAA enlargement, stability, or shrinkage. Also, the
prevailing opinion was that some endoleaks could not be
classified despite all efforts to do so and that AAA enlarge-
ment could sometimes occur in the absence of an endoleak
and AAA shrinkage could occasionally occur despite the
presence of an endoleak.
The presence of endotension without a visualized
endoleak indicates the presence of an endoleak that is
sealed (clotted) or otherwise not visualized? Sixteen of
the 26 respondents agreed. Thus, the prevailing opinion
was that endotension indicated the presence of a sealed or
clotted endoleak (ie, a “virtual endoleak”). One comment
indicated that pressure can be transmitted through clot, a
point on which general agreement existed. Another com-
ment suggested that pressure could be transmitted to the
AAA sac through an intact graft, and another comment
indicated that infection in the excluded AAA sac could
result in endotension without an endoleak.
Type II endoleaks after endovascular abdominal
aortic aneurysm repair usually produce systemic pres-
sures within the abdominal aortic aneurysm sac? Four-
teen of 26 respondents agreed. Thus, prevailing opinion
was that type II endoleaks could produce systemic pressures
within the AAA sac. However, 10 participants disagreed
and two were uncertain, indicating some disagreement on
this important point.
Table II. Classification scheme for endoleaks and
endotension
Description
Endoleaks*
(type) source of perigraft flow
I Attachment site leaks†
A Proximal end of endograft
B Distal end of endograft
C Iliac occluder (plug)
II Branch leaks‡ (without attachment site
connection)
A Simple or to-and-fro (from only 1 patent branch)
B Complex or flow-through (with 2 or more patent
branches)
III Graft defect†
A Junctional leak or modular disconnect
B Fabric disruption (midgraft hole)
Minor (2 mm; eg, suture holes)
Major (2 mm)
IV Graft wall (fabric) porosity (30 days after graft
placement)
Endotension§
Type
A With no endoleak
B With sealed endoleak (virtual endoleak)
C With type I or type III leak
D With type II leak
*Endoleaks also can be classified on basis of the time of first detection as:
perioperative, within 24 hours of EVAR; early, 1-90 days after EVAR; and
late, after 90 days. In addition, they can be described as primary, from time
of EVAR; secondary, appearing only after not being present at time of EVAR;
and delayed, occurring after prior negative CT scan results. Endoleaks also
can be described as persistent, transient or sealed, recurrent, treated success-
fully, or treated unsuccessfully. Endoleaks and endotension may be associated
with AAA enlargement, stability, or shrinkage.
†Some type I and type III leaks also may have patent branches opening from
AAA sac and providing outflow for leak.
‡From lumbar, inferior mesenteric, hypogastric, renal, or other arteries.
§Endotension (strict definition) is defined here as increased intrasac pressure
after EVAR without visualized endoleak on delayed contrast CT scans. In
generic sense, endotension is any elevation of intrasac pressure and occurs
with type I, type III, and most type II leaks and endotension in strict sense.
Detectable only on opening aneurysm sac.
JOURNAL OF VASCULAR SURGERY
May 20021032 Veith et al
Prevailing Opinion Relating to the Behavior or
Diagnosis of Endoleaks and Endotension
What percentage of type II endoleaks produce bad
outcomes? Answers ranged from 0 to 50%, with a mean of
16%. Fifteen of 26 respondents (prevailing opinion) be-
lieved that 2% to 15% of type II endoleaks were associated
with bad outcomes. However, two participants com-
mented that this may be because of an unrecognized type I
leak.
Stability or absence of shrinkage in abdominal aor-
tic aneurysm diameter after endovascular abdominal
aortic aneurysm repair is indicative of endotension or
endoleak or both? Fifteen of the 26 respondents dis-
agreed. Thus, the prevailing opinion was that stability of
AAA size does not necessarily indicate the presence of an
endoleak or endotension. Comments were that large aneu-
rysms (6 cm in diameter) may not shrink and that AAA
shrinkage may take years and depends on the type of
endograft used.
Prevailing Opinion Relating to Abdominal Aortic
Aneurysm Pulsatility and Endoleaks and Endotension
If an abdominal aortic aneurysm is pulsatile after
endovascular abdominal aortic aneurysm repair, it is
evidence of an endoleak? Fifteen of the 26 respondents
disagreed. Nine agreed, and two were uncertain. Thus,
prevailing opinion existed that pulsatility after EVAR was
not evidence of an endoleak. Two comments indicated that
such AAA pulsatility after EVAR was worrisome but incon-
clusive.
Divided opinions or disagreement existed on the
answers to the following questions.
What percentage of type I endoleaks seal and have
no detrimental effect? Answers ranged from 0 to 50%,
with a mean of 15.5%. A clearly bimodal distribution of
answers was seen, with 10 participants answering that none
sealed and that immediate treatment was necessary. Nine
other respondents thought that 10% to 50% could seal but
rarely after 2 weeks. One comment indicated that all sealed
type I leaks will recur.
Occlusion of both hypogastric arteries when neces-
sary is a reasonably safe procedure and carries an ac-
ceptable risk? Twelve of 26 respondents agreed, nine
disagreed, and five were uncertain. Thus, an obvious differ-
ence of opinion existed on this issue.
DISCUSSION
Endoleaks are a major unsolved problem when aor-
toiliac aneurysms are repaired with endovascular grafts. Yet
the nature and significance of these endoleaks in individual
patients remain unclear. Moreover, the definition and con-
sequences of endotension and the exact relationship be-
tween endotension and endoleaks continue to be contro-
versial. This conference process was designed to clarify the
nature and significance of these endoleaks and endoten-
sion, to elucidate the relationship between these two com-
plications, and to provide an overview of current knowl-
edge and opinion regarding these two vexing problems that
impact on the rapidly advancing field of EVAR. That many
of the consensus opinions expressed within this process will
change as new knowledge accumulates is recognized. As
one participant (Wolf Stelter) commented, “Truth in sci-
ence cannot be found by voting for it.” Nevertheless, it is
likely that the conclusions of this conference process will
provide useful information on the incidence of endoleaks
and methods to diagnose and treat them. Hopefully, these
conclusions will also be helpful to others in the manage-
ment of specific patient problems and in pointing the way
toward investigations designed to advance knowledge and
to clarify uncertainties.
Despite the potential limitations of conference conclu-
sions, several areas of current agreement deserve emphasis.
That in some circumstances elevated pressure can be trans-
mitted through clot now appears likely.17-20 This explains
why coil embolization of type I or type II endoleaks may be
ineffective. This also explains why some AAAs enlarge even
when no endoleak can be detected and why endotension
may occur without an endoleak.12 However, other as yet
unproven mechanisms may contribute to endotension and
AAA enlargement in the absence of an endoleak.15
That type II endoleaks, although often benign and
associated with AAA stability or shrinkage,21 can lead to
AAA enlargement and rupture and that this can occasion-
ally occur when the leak appears to have been sealed by clot
is now clear.7,22,23 It is also becoming increasingly well
recognized that type II endoleaks can produce intrasac
pressures in the systemic range and that translumbar embo-
lization is a more effective method for diagnosis and treat-
ment.16 However, this remains to be proven, and laparo-
scopic clipping of branches remains a popular alternative.24
The conference produced general agreement that sim-
ple CT scan diameter measurements were adequate to
determine AAA size changes after EVAR. Volume meas-
urements, although superior and a valuable research tool,
were believed to be too cumbersome for general usage.
However, several participants commented on difficulties
that could occur with making accurate AAA diameter meas-
urements on CT scan and that efforts should be made to
avoid these pitfalls when determining diameter changes.
Several past concepts were clarified or corrected with
the conference process. AAA pulsatility after EVAR was
agreed to be a poor index of the presence or absence of an
endoleak and endotension.15,25 Furthermore, although
some investigators in the past have believed that failure of
AAA shrinkage or size stability after EVAR was evidence of
an endoleak or endotension, the current prevailing opinion
was that this was not so, particularly with large AAAs.
Moreover, CT scanning was generally agreed to be a better
diagnostic method for endoleak detection than duplex
ultrasonography.
General agreement existed on several items that point
the way toward future research requirements. Improved
techniques for diagnosis of endoleaks and particularly en-
dotension are needed. Presently no method exists to meas-
ure intrasac pressure noninvasively. Also agreed was that
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hypogastric arteries or branches should not be allowed to
retain open communication with the sac of aortoiliac or
iliac aneurysms and that unilateral hypogastric emboliza-
tion was justified. However, bilateral hypogastric occlusion,
although sometimes justified, was believed to be best
avoided. How often this was justified or what would be the
best method to avoid it (hypogastric revascularization or
branched endografts) was not certain at present.
The modified classification scheme (Table II) was in-
troduced to permit a more detailed categorization of en-
doleaks and endotension. With endoleaks, this system is
consistent with the classification proposed by The Society
for Vascular Surgery/American Association for Vascular
Surgery ad hoc committee on standardized reporting prac-
tices for EVAR,26 although it does further subclassify type
II leaks in a way that may explain why some behave differ-
ently. This will hopefully facilitate communication between
investigators and lead to more accurate analyses of the
natural history and the effectiveness of treatment methods.
The Society for Vascular Surgery/American Association for
Vascular Surgery classification includes, in addition to types
I to IV, “ endoleaks of undefined origin” explained as “flow
visualized but source undetermined.”26 The classification
does not classify endotension under endoleaks, but we have
added a classification of endotension in the second part of
Table II. This underscores our definition of endotension.
Obviously, pressure is elevated within an aneurysm sac after
EVAR with all types of endoleaks (endotension in the
generic sense). However, the strict usage of the term endo-
tension within our classification scheme is reserved for
circumstances in which the intrasac pressure is elevated
without a demonstrable endoleak on a delayed contrast CT
scan. This definition and classification scheme will permit a
more accurate categorization of the circumstances in indi-
vidual patients. This in turn will permit more accurate
determination of natural history and prognosis and more
precise application of the most appropriate treatment.
The classification scheme presented in Table II includes
a category for endotension without any endoleak (endoten-
sion, type A) even at open operation, and we and others
have described such cases. It also includes a category (en-
dotension, type B) with a sealed or clotted endoleak. This
would be considered a virtual endoleak because there is no
blood flow outside the grafts in the sac. Only when clot is
removed from the branch orifice at operation does the leak
become apparent, and we have had such a case.23 In addi-
tion, patients with a type I or type III endoleak may not
have it visualized on a CT scan but still have a high intrasac
pressure (endotension, type C); and patients with a type II
endoleak may not have a leak visualized but still have a high
intrasac pressure (endotension, type D). In these latter two
categories, the endoleak only becomes apparent when the
aneurysm sac is opened at operation. Whether patients with
type C and type D endotension behave like those with type
I and III leaks and type II leaks, respectively, remains to be
determined.
In conclusion, the conference process achieved remark-
able agreement among leaders in the field from many
countries. Hopefully, this agreement will be helpful in
guiding current patient management. In addition to reach-
ing agreement or near agreement on a number of complex
and controversial issues, all the participants agreed that
much remained to be learned about endoleaks and endo-
tension and how they may be prevented and treated. These
perplexing problems will continue to be a challenge to the
success of EVAR and will have to be addressed aggressively
by those interested in the field. Until solutions of these
problems are found, EVAR will remain an imperfect long-
term treatment and continued periodic follow-up examina-
tion to detect and treat these problems will be mandatory.
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